Takai


Takaaki Takai

President, Kyoritsu Seiyaku Corporation & Director, Carus

Experience:

Takaaki is a charismatic figure who started Calmic Japan Limited, a joint venture with Rentokil Initial PLC UK, in 1969 and rapidly grew this into a successful business which employs 700 people with an annual sales turnover of £97 million. In 2011, Takaaki became the President of Kyoritsu Seiyaku Co. Ltd. Established in 1955, with 600 employees and a turnover of £310 million, Kyoritsu Seiyaku Co. Ltd is the number one animal health company in Japan and ranked eleventh globally. He values relationships with people and has an extensive network in multiple sectors which he uses to strengthen business development opportunities.  Takaaki has a driven leadership style that is focused on achieving targets.

Personal: He is a huge rugby fan. Attending the Brighton Community Stadium on 20th September 2015, he cheered the Japanese National Team on with a strong belief of victory when no one believed it possible they could beat South Africa!

Carus-7_50pc

Ron Long

Chairman

Experience: Ron brings a wealth of experience from the Life Science and Pharmaceutical industry and sits on the Board of a number of companies. Ron began his career working for the Wellcome Foundation PLC for 22 years culminating in a number of Divisional Director and Managing Director appointments. These included serving on the Board of Coopers Animal Health, a top five global health company created following a merger between Wellcome and ICI’s veterinary businesses. The company’s Japanese partner was Kyoritsu Seiyaku.

Since leaving Amersham, Ron has held a range of Executive and Non-Executive roles with a number of Life Science Pharmaceutical and Diagnostic companies in the UK and Sweden. Ron is currently Chairman of Better All Round Ltd, Chairman and CEO of Euro-Diagnostica AB and Executive Chairman of Sky Medical Technology Ltd. Ron was elected as a member of the Royal Swedish Academy of Engineering Sciences, IVA in March 2010.

Ron went on to join Amersham PLC as a Board member from 1990 to 2001, holding a number of senior roles including CEO of Amersham Pharmacia Biotech and Executive Vice Chairman of the Group.

Since leaving Amersham, Ron has held a range of Executive and Non-Executive roles with various Life Science Pharmaceutical and Diagnostic companies in the UK and Sweden. Ron is currently Chairman of Better All Round Ltd, Chairman and CEO of Euro-Diagnostica AB and Executive Chairman of Sky Medical Technology Ltd. Ron was elected as a member of the Royal Swedish Academy of Engineering Sciences, IVA in March 2010.

Personal: In rare moments when he is not working, Ron spends most of his spare time with his family. He enjoys music (playing the guitar and piano), gardening and the occasional spot of fishing.

Carus-8_50pc


Hisanori Ken Tsukahara

CEO

Experience: Ken has 15 years’ experience working in the consulting industry. He started his career with PwC which  subsequently became part of IBM, and worked in its business consulting division for 9 years. He then worked at Accenture for four years and another two years at KPMG. As a global operation and IT innovation consultant working mainly in the business strategy, sales, logistics and procurement areas, Ken has delivered 18 projects for major companies in various industries, including consumer electronics, manufacturing and e-commerce retailing.

Ken is adept at understanding the needs of clients and is focused on promoting and delivering new initiatives in the animal health industry at a global level.

Personal: Married with one daughter, Ken plays tennis and also swims and jogs to keep himself in good shape. He likes to travel to various places and he recently relocated from Tokyo to London and is very much looking forward to travelling around Europe.

Carus-3_50pc


Jolian Howell

Commercial Director

Experience: Jolian Howell is commercial director at Carus Animal Health. He has over 20 years’ experience in the animal health sector with several leading companies including MSD, Zoetis, Pfizer, Novartis and Leo in a variety of commercial positions both in the UK and the EU.

Jolian began his career in animal health as a sales representative, then moved into marketing to manage the Rimadyl (Carprofen) brand. Following the creation of a central European function at Pfizer, Jolian relocated to Paris to take on the newly created role of European Brand Team Leader, launching both Cerenia and Trocoxil across the EU region.

Since 2007 he has led teams at a European level and been a member of the European Business Unit leadership team. This involved working in a variety of European marketing and strategic planning positions across multiple species sectors, to bring new medicines from clinical trial development to a pre-launch, and subsequently to full commercial launch. In 2010 he led the integration process between the Pfizer and Fort Dodge equine business units. This involved supporting local countries to develop operational teams and establish a business unit portfolio through new product development, phase IV planning, geographic expansion and licensing.

Following a return to the UK in 2013, Jolian led the marketing and technical team that oversaw the launch of Bravecto, a novel innovation in the ectoparasiticide sector. To further broaden his healthcare experience, he entered the human health dental sector with Simplyhealth leading the marketing team for Denplan.

Carus focuses on developing an innovation led portfolio and novel life science technology platforms for application in the animal health sector. Jolian is looking forward to shaping this strategy and partnering with organisations to achieve these goals.

Personal: With four children he has a busy home life keeping the peace but when he does find the time enjoys cross country and water sports.

Carus-2_50pc


Rich Irvine BVSc MRCVS

Technical Director

Experience: Rich is a veterinary surgeon and is passionate about providing the best possible care for animals, whether directly under his care or more globally through his work in the animal health industry.  He worked in the human pharmaceutical industry before, and while qualifying as a vet in 2004. Rich has practiced in a number of first opinion and charity clinics & hospitals throughout the South East & London, and gained extensive experience as a locum vet before moving full time into the veterinary pharmaceutical sector, working with a number of leading animal health companies.

He has developed a strong interest in anaesthesia and analgesia, and maintains memberships of the Association of Veterinary Anaesthetists and the anaesthesia section as a Fellow of the Royal Society of Medicine in London.

Rich is experienced in new product development and clinical trial work, as well as the technical support, pharmacovigilance and sales and marketing of established veterinary products through working for animal health companies and as an independent consultant.

Rich joins Carus as the company’s first Technical Director and is excited to embrace the new technology and discovery tools needed to achieve Carus’s mission to be a  leader in veterinary innovation. Rich will primarily be responsible for seeking and evaluating new products and technology, liaising with academic centres of excellence, technical due diligence, implementing a portfolio management system, defining and controlling the development portfolio and managing development projects including clinical studies.

He is keen to hear from scientists, innovators and clinicians who would like to explore potential partnerships with Carus.

Rich is a Member of the Royal College of Veterinary Surgeons, a fellow of the Royal Society of Medicine and holds memberships with the AVA, BVA and BSAVA.

Personal: In his personal time Rich loves cooking and entertaining. He also enjoys design, build and renovation. He has a wonderful and supportive fiancé and together they have a family of two cats and two chickens. They are hoping to add a dog and some highland cattle to this furry family shortly!

Carus-6_50pc


Etsuko Hosaka

Finance & Administration Manager

Experience: Etsuko has 20 years’ experience working in the pharmaceutical industry, initially in Japan for Amersham K.K. before moving to the UK headquarters in 1996 to manage the liaison office for the JV between Sumitomo Chemical and Amersham International PLC, (latterly GE Healthcare).

Etsuko has held various roles both in commercial and manufacturing operations, including business development, in-licensing, business intelligence, strategic development and quality management in the global supply chain – working with major manufacturing sites in the UK, Norway and North America for product supply into the Japanese market. Etsuko left GE Healthcare Ltd in 2009, taking up a consultancy role to manage pharmaceutical product supply, GMP quality management and auditing for her Japanese client, Nihon Medi-Physics Co. Ltd.

Personal: Married with two sons, Etsuko has various interests outside work including devoting a considerable amount of time to her role as PSA Vice Chair of the Japanese Saturday School in London.

Carus-1_50pc


Greg Firth BVetMed, CertVOphthal, PhD, MRCVS

Veterinary Advisor

Experience: Greg is a veterinary surgeon with experience in both first and second opinion practice. He graduated from the Royal Veterinary College in 1992 and was appointed House Surgeon at Glasgow University Veterinary School. Following his return to London as a Wellcome Trust Veterinary Clinical Training Scholar, he was awarded a PhD and went on to work as a molecular biologist for Nycomed Amersham PLC.

Greg subsequently returned to a clinical career path, initially working in mixed general practice before founding a companion animal practice, of which he remains a director.

Personal: When not working, Greg enjoys spending time with his family, exploring the natural charms of the Peak District National Park and playing sport and music.